Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis

Moon Haeng Hur, Yuri Cho, Do Young Kim, Jae Seung Lee, Gyoung Min Kim, Hyo-Cheol Kim, Dong Hyun Sinn, Dongho Hyun, Han Ah Lee, Yeon Seok Seo, In Joon Lee, Joong-Won Park, Yoon Jun Kim

Clin Mol Hepatol. 2023;29(3):763-778. Published online May 30, 2023

DOI: https://doi.org/10.3350/cmh.2023.0076

View: 2687 Download: 177 Crossref: 1

Review

Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma

Edward Wolfgang Lee, Sarah Khan

Clin Mol Hepatol. 2017;23(4):265-272. Published online November 8, 2017

DOI: https://doi.org/10.3350/cmh.2017.0111

View: 10936 Download: 359 Web of Science: 38 Crossref: 34

Radioembolization for the treatment of hepatocellular carcinoma

Hyo-Cheol Kim

Clin Mol Hepatol. 2017;23(2):109-114. Published online May 10, 2017

DOI: https://doi.org/10.3350/cmh.2017.0004

View: 12224 Download: 362 Web of Science: 46 Crossref: 41

Case Report

Gastrectomy for the treatment of refractory gastric ulceration after radioembolization with ⁹⁰Y microspheres

Sun Young Yim, Jin Dong Kim, Jin Yong Jung, Chang Ha Kim, Yeon Seok Seo, Hyung Joon Yim, Soon Ho Um, Ho Sang Ryu, Yun Hwan Kim, Chong Suk Kim, Eun Shin

Clin Mol Hepatol. 2014;20(3):300-305. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.300

View: 7858 Download: 58 Web of Science: 8 Crossref: 10

1 |

Viewed By 5168	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5025	MAFLD: How is it different from NAFLD?
Viewed By 4971	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3646	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3603	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 51	MAFLD: How is it different from NAFLD?

Search